Vestal Point Capital, LP: TAYSHA GENE THERAPIES INC (TSHA): Quarterly 13F Position History
As of Q2 2026, Vestal Point Capital, LP reported 19,415,000 shares of TAYSHA GENE THERAPIES INC (TSHA), worth $132.2M and representing 3.1% of its 13F equity book. Quarter-over-quarter share count change: + 1,415,000 (+7.9%) . The position first appeared in Q2 2025 and has been disclosed across 5 13F-HR filings in Pactolio's tracked window.
- 19,415,000Shares Held (Latest Filing)
- $132.2MReported Market Value (Latest Filing)
- 3.1%Portfolio Weight (% of 13F Equity Book)
- +1,415,000Quarter-over-Quarter Share Change
- +$51.8MQuarter-over-Quarter Value Change
- 19,415,000Peak Reported Shares (Historical)
Quarterly 13F-HR Disclosure History Source: SEC 13F-HR filings, 5 quarter s
| Quarter | Shares | QoQ Share Change | Share Change (%) | Market Value | Weight | Implied Price |
|---|---|---|---|---|---|---|
| Q2 2026 | 19,415,000 | +1,415,000 | +7.9% | $132.2M | 3.1% | $6.8 |
| Q1 2026 | 18,000,000 | +4,250,000 | +30.9% | $80.5M | 2.2% | $4.5 |
| Q4 2025 | 13,750,000 | +8,250,000 | +150.0% | $75.6M | 2.8% | $5.5 |
| Q3 2025 | 5,500,000 | +2,500,000 | +83.3% | $18.0M | 0.8% | $3.3 |
| Q2 2025 | 3,000,000 | – | – | $6.9M | 0.4% | $2.3 |
Methodology & FAQ
How This Position History Is Sourced
Each row is one SEC Form 13F-HR filing disclosing this position. Share count, market value, and reported quarter are taken verbatim from the filing; portfolio weight is recomputed against the same filing's total reported equity book. Implied price-per-share is market value divided by shares, a quarter-end mark rather than the manager's cost basis. See the full methodology document for the normalization rules.
When did Vestal Point Capital, LP first disclose a TSHA position in 13F-HR filings?
Vestal Point Capital, LP first reported TAYSHA GENE THERAPIES INC (TSHA) on its 13F-HR filing for the period ending 2025-06-30 (Q2 2025). The position has appeared on 5 reported quarters within Pactolio's tracked window.
What was Vestal Point Capital, LP's most recent quarter-over-quarter share-count change in TSHA?
Between Q1 2026 and Q2 2026, Vestal Point Capital, LP added 1,415,000 shares of TSHA (+7.9%), bringing the total reported position to 19,415,000 shares at a market value of $132.2M.
Does the implied price-per-share represent Vestal Point Capital, LP's cost basis in TSHA?
No. The implied price-per-share column is the 13F-HR reported market value divided by reported share count on the filing date (end of quarter). It is a quarter-end mark, not a cost basis or transaction price. Use it as a sanity check on the value column, not as an indicator of the manager's entry or exit price.